NewSquare Capital LLC Purchases 4,854 Shares of CVS Health Corporation $CVS

NewSquare Capital LLC lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 4.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,518 shares of the pharmacy operator’s stock after purchasing an additional 4,854 shares during the quarter. NewSquare Capital LLC’s holdings in CVS Health were worth $7,595,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in CVS. Avion Wealth boosted its position in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health in the 2nd quarter worth about $30,000. Bell Investment Advisors Inc increased its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the last quarter. Roxbury Financial LLC increased its stake in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares during the last quarter. Finally, ORG Partners LLC increased its stake in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 377 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Activity

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.22% of the company’s stock.

CVS Health Stock Up 0.4%

CVS opened at $78.48 on Tuesday. The company has a 50 day moving average of $76.64 and a 200 day moving average of $69.12. The company has a market cap of $99.62 billion, a PE ratio of 206.52, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same period last year, the firm earned $1.09 EPS. CVS Health’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s payout ratio is currently 700.00%.

Analyst Upgrades and Downgrades

CVS has been the subject of several analyst reports. The Goldman Sachs Group initiated coverage on shares of CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 price objective for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. Raymond James Financial increased their price objective on shares of CVS Health from $75.00 to $90.00 in a research note on Friday. Truist Financial restated a “buy” rating and set a $95.00 price target (up previously from $92.00) on shares of CVS Health in a research note on Thursday, October 30th. Finally, Wolfe Research raised their price target on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $88.82.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.